Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung | Lex Fridman Podcast #502
Is it worth your time?
You get a detailed historical account of psychiatry's failures and the systemic flaws in modern drug treatments and diagnostic frameworks.
This conversation explores the troubled history and current crisis of psychiatry, examining how centuries of biological theories led to brutal interventions and inadequate drugs. It investigates why standard diagnostic categories fail and how the profession can better address profound human suffering.
The crisis in psychiatry. Scull argues that modern psychiatric diagnoses rely on symptom checklists rather than underlying pathology, a system formulated with the 1980 DSM-III to ensure administrative reliability rather than medical validity. This symptom-based approach led to an explosion of diagnostic categories and billions spent on neuroscience research that failed to produce biological markers or cures. Consequently, major psychiatric drugs remain only partially effective, leaving patients with serious mental illness dying fifteen to twenty-five years earlier than the rest of the population.
Lobotomies and shock therapies. Scull notes that the history of psychiatry contains uncontrolled physical experiments driven by misplaced biological optimism, ranging from surgical lobotomies to insulin comas and unmodified electroconvulsive therapy. Freeman popularized the ice pick lobotomy by driving an ice pick through the eye socket and severing brain connections in thousands of patients. While these extreme methods were often used as tools of behavioral control in overcrowded institutions, some patients with severe depression still find electroconvulsive therapy lifesaving despite memory side effects.
Antipsychotics and antidepressants. Scull explains that the 1950s pharmaceutical revolution introduced major tranquilizers and selective serotonin reuptake inhibitors by accident, offering symptomatic relief rather than cures. These psychotropic drugs fail to work for a significant fraction of patients and carry severe side effects, such as tardive dyskinesia from antipsychotics and emotional numbing or sexual dysfunction from antidepressants. Major drug companies manipulated clinical trial data and abandoned mental illness research because they could make more money researching other diseases, leaving the profession stuck with aging treatments.
Talk therapy and psychosocial support. Scull suggests that psychiatry needs to move away from purely technocratic pill-dispensing and broaden its research to include psychosocial dimensions and talk therapies like cognitive behavioral therapy and psychoanalysis. Although psychoanalysis was largely pushed out of mainstream medicine, talk therapy and social support remain vital for addressing the root causes of human distress and isolation. Ultimately, he warns that losing scientific rigor and public trust through overhyped breakthroughs will severely damage the profession's ability to help vulnerable patients.
Crisis in Psychiatry
Despite some progress over the past century, we are still not good at treating mental illness via psychopharmacology or psychotherapy—the brain or the mind route. Psychiatry tries to deal with an enormously complicated thing: the human mind, emotions, and the ability to understand the world. It focuses on people where our common sense approach breaks down: those whose emotional lives are filled with turmoil, whose ability to relate to others is badly damaged, or who experience illusions, hallucinations, and delusions.
Clever minds have occupied themselves with this subject for years, and there has been limited progress in dealing with the problems mental illness creates. Some of that is confined to milder forms of distress; in more serious psychosis and breakdowns of emotional control, it is easy to overstate the progress made. The advent of modern psychopharmacology in the early nineteen fifties was a serendipitous, unplanned accident. This revolution, and a parallel one in psychotherapy, created advances for patients that we should not minimize.
However, we have symptomatic treatments, not cures; we don't have a psychiatric penicillin for any of these conditions. The help is limited, and we must understand that our interventions sometimes create iatrogenic problems. For example, in treating PTSD, we often have patients confront the trauma that provoked their distress. This fraught process makes things better for some, but for many, it actually makes things worse.
Antipsychotics and antidepressants, our two main classes of psychotropic drugs, are at best partially effective and don't work for a significant fraction of patients. A major problem is that psychiatrists don't know in advance who will respond well or badly. For those in the middle, the therapeutic effects and side effects are finely balanced, making judgment calls very difficult.
I see several strands pointing to the current crisis in psychiatry. The fundamental basis of psychiatric diagnosis was first formulated in 1980 with the DSM-III, followed by DSM-III-R, DSM-IV, DSM-IV-TR, and now DSM-5, modified like a piece of software. This system emerged because psychiatrists struggled to agree on diagnoses, which became embarrassingly clear in professional literature and via David Rosenhan's scientific fraud, "On Being Sane in Insane Places," where pseudo-patients were diagnosed as schizophrenic or bipolar.
In a panic after that study appeared in Science, and given 1960s literature showing diagnosis was an erratic process, the DSM-III task force led by Robert Spitzer at Columbia created a "tick the boxes" approach. To construct these boxes, they relied on symptom lists; for example, if you had six of ten symptoms of a certain sort, you could be diagnosed with major depression.
The system was partially embedded because it appealed to drug companies developing treatments, insurance companies seeking a stable base, and patients and families scrambling to deal with enormous upsets in their mental lives. However, this was based simply on symptoms, similar to how an eighteenth-century doctor might diagnose dropsy or fever—labels that actually covered constellations of very different things. This approach was all psychiatry could come up with to ensure that whether you were in Walla Walla, New York, San Francisco, or Atlanta, you reached the same conclusion. That didn't necessarily mean it was a valid diagnostic system; reliability means two people reach the same conclusion from the same facts, but that conclusion may not reflect the underlying reality.
As the system went through iterations, the number of possible psychiatric disorders grew until some categories became difficult to believe in. Beyond that, psychiatrists wanted to be like other medical doctors by rooting diagnoses in an understanding of underlying pathology. When the DSM-5 was mooted in the early 2000s, the National Institute of Mental Health (NIMH)—under Steven Hyman and later Thomas Insel—invested heavily in the idea that mental illness was brain disease, focusing on genetics and neuroscience.
NIMH was founded in the late 1940s to conduct basic research, train people, advance care, and produce cures. Since the 1990s, when the first George Bush declared the decade of the brain, NIMH increasingly focused on mental illness as purely a brain disease. There is something to that, but also a mistake in thinking about it that way. This approach appealed to medical school deans because money flooded in from the NIH and drug companies funding basic research on neurobiology and genetics, followed by insurance companies.
Human brains are remarkably plastic, developing in response to the environment; social and psychological factors are embedded in our brains, and epidemiological evidence shows they play an important role in the development of illness.
Freud simplified the human mind toward a particular view. To encapsulate the problem, Leon Eisenberg, who had a long career at Harvard, said toward the end of his career, "When I entered psychiatry, it was brainless psychiatry, leaving it mindless psychiatry." Freudians tended to neglect the biological, suggesting the brain as a biological organism was not something we needed to worry about.
When antipsychotic drugs were discovered in the early 1950s, we had no clue how they worked. We began to understand that the brain wasn't just a set of electrical signals, as thought in the first half of the 20th century and before, but rather a chemical soup of neurotransmitters that help the brain work and perhaps explain why it goes awry. The first neuroscience conventions in the 1970s attracted a few hundred people; now, there are tens of thousands of neuroscientists.
The categories we've become familiar with as real diseases—like bipolar disorder, schizophrenia, and major depression—are beginning to falter. We worry whether those diagnoses are real ways of thinking about the world or if they mislead us, which is what DSM-V thought it could address but discovered it couldn't.
Looking at the history, DSM-I in 1952 was a 32-page pamphlet with 106 diagnoses heavily influenced by psychodynamic concepts and etiology using broad, vague categories like reactions. DSM-II in 1968 expanded to 185 diagnoses, still psychodynamically flavored with poor reliability, but added attention to childhood disorders and removed homosexuality as a disorder in the 1974 printing. The revolution came with DSM-III in 1980, which introduced explicit symptom-based diagnostic criteria, a multi-axial assessment system, and an officially atheoretical stance about causes to improve reliability and research utility. DSM-III R in 1987 revised criteria and expanded to around 297 diagnoses. DSM-IV in '94 and DSM-IV TR in 2000 focused on literature-driven empirical revisions, adding and deleting disorders and increasing coordination with ICD-10. Finally, in 2013, DSM-5 eliminated the multiaxial system, integrating information into a single nonaxial diagnostic list with separate notations for psychological and medical factors, and introduced new and refined entities like neurodevelopmental, obsessive-compulsive related, and trauma and stress related disorders. Conceptually, the DSM moved from cause-focused and psychoanalytical to symptom-based, atheoretical, and reliability-driven.
You invest more than $20 billion in a particular approach. At the time of construction, you say, "Finally, because of all the work being done in genetics, we have decoded the human genome." We have PCR to chop it up and look at bits of it, and a much greater understanding of the role of neurotransmission in the brain.
We'll be looking at the actual underlying pathological changes that have taken place. By about 2008, they had thrown up their hands and decided to continue relying upon the same basic approach developed in 1980. When that document came out, Robert Spitzer, who had largely controlled DSM-III and DSM-III-R, and his successor Allen Frances, who ran DSM-IV, were both fiercely critical, saying it was done in secrecy, in the dark, and wasn't scientific. Thomas Insel and Steven Hyman, the then existing and preceding directors of the National Institute of Mental Health, also denounced the document as unscientific and useless.
The difficulties with existing therapies had become more manifest. To make matters worse, Big Pharma had behaved unethically, hiding things that undercut their claims, manufacturing studies, and manipulating data. They were caught and paid billions of dollars in damages for these tricks. This wasn't just in psychiatry; for example, the painkiller Vioxx was another huge scandal with a $5 billion settlement. Unfortunately, neuroscience hadn't thrown up new targets for different forms of drug development, and companies decided they could make more money researching other diseases rather than mental illness.
We were stuck with a set of drugs that Steve Hyman says aren't any advance on the ones found by accident in the fifties. With no new research except from small startups, your diagnostic process falls apart and drug treatment limitations become more manifest. People with serious mental illness die, on average, fifteen to twenty-five years before the rest of us, and that gap has been growing. Much of this is public policy that has abandoned treatment for the seriously mentally ill. Shockingly, the three largest centers of inpatient psychiatric care in the United States today are the Los Angeles County Jail, Cook County Jail in Chicago, and Rikers Island in New York, though prisons aren't equipped to deal with serious mental illness.
Asylums had acquired a very bad reputation, but when they were founded, there was enormous optimism that we could rescue people from attics and jail cells. By providing a therapeutic environment, coaxing them to work, and creating a system where they learned to control themselves—not necessarily to drive their demons out, but to keep them under wraps—the earliest alienists thought they could cure 60, 70, or 80 percent of patients if they arrived early. This optimism was replaced by something called community care, but community care is a shell game without a pea; there were no substitute community facilities for dealing with the really serious mentally ill.
Categories of Mental Illness
In the early 20th century, German psychiatrist Emil Kraepelin used thousands of asylum records to inductively develop a distinction between two broad categories of mental illness. He called one dementia praecox, or early dementia—a one-way ticket down—and the other manic depressive illness, a more remitting condition that sometimes went away entirely or fluctuated.
Swiss psychiatrist Bleuler transformed that label into the term schizophrenia, though he spoke of "the schizophrenias" because he believed a diverse group of things existed under that broad label. This jammed together people with serious psychosis who had lost touch with reality, whose emotional and cognitive lives were in total turmoil, and who lost the ability to connect with others. Their social skills atrophied, which contemporary psychiatrists refer to as the positive and negative symptoms of schizophrenia. Underlying this definition is a detachment from reality: hearing voices, seeing visions, thinking people are plotting against you, or believing the television is talking directly to you. Your emotional life flattens, your language capacity deteriorates, and your ability to relate to others either vanishes or becomes caught up in a web of delusions.
Ancient Greece and Rome recognized different forms of insanity. They used the term melancholia, which survived for a long time. Now, major depression has become a catchall category embracing both milder emotional distress and what melancholia referred to: depression with psychotic features. We grapple with people whose depression is of such a scale they threaten to do away with themselves, retreat into complete immobility, or are overwhelmed by sadness, loss, and beliefs that they are damned to hell.
The ancients also recognized dementia, the loss of our mind. In the 19th century, neurosis meant things rooted in the brain, while psychosis referred to things coming from the mind, the psyche. The most severe mental disorders include Alzheimer's and other dementias, serious depression, and bipolar disorder. In bipolar disorder, people oscillate between depression and extreme mania, where they don't sleep, talk at an extraordinary rate, and exhibit behavior that is hard to tolerate, potentially dying from exhaustion if uncontrolled. This category was initially captured as manic depressive illness before evolving into bipolar disorder and separating out major depression.
Other conditions include phobias, such as people who cannot go outside, cannot board an airplane for fear it will crash, or suffer from school phobia. Then there is hysteria, a disorder that first attracted Freud. Every classification we've discussed has been used and abused by every layer of society and institutions; culturally, the word hysteria was applied disproportionately to different races and genders as we struggle to figure out what to do with the super complicated human mind.
Asylums, Eugenics, and the Nazis
Looking back at the asylum era born in a period of intense optimism, the claims to cure vast numbers of patients were overblown. I believe early asylums did good work and some patients recovered; they were discharging 35% or 40% of their patients. However, every year left behind a batch of chronic patients, and over time the ratio of new to chronic patients worsened. The image of the asylum became defined by the chronic patient who spent years or decades there and only left in a pine box.
As asylums became overcrowded, conditions deteriorated and patients were often abused. Psychiatrists faced a problem in the late 19th century: they had promised 70% or 80% cures, but calculations showed it was more like 10% or 12% because old patients were mixed with the new. The answer came by blaming the victim, claiming mental illness was a fundamentally biological condition and these people were evolutionary throwbacks. While evolution was thought of as progressive, these people had fallen back into a lesser form of existence, losing their essential humanity because their brains were defective.
This birthed the idea of degeneration—that these patients were degenerates with an inferior biology. This provided a justification for locking people up in asylums that wasn't therapeutic at all. It led to the justification of sterilization; the logic was that they could be released if they couldn't breed, as they supposedly bred like rabbits and lacked self-control. My own state was a pioneer in this process, sterilizing mental patients until about 1960. By then, over 60,000 sterilizations had been performed in the US, with California performing a disproportionately high number. One British psychiatrist even said that if his patients had been puppies, he would have tied them in a sack with lead weights and drowned them because they were horrible mongrels, not purebreds.
California's sterilization laws were advocated for across North America, Britain, and much of Europe. In democratic systems, checks and balances prevented eugenicists who wanted to put these people to death from acquiring mass support. But when the Nazis came to power in Germany, they seized on these notions, calling the mentally ill "useless eaters" who were a burden on the state with lives not worth living. After sterilization, Hitler started the T4 program, named after Tiergartenstraße 4. The mentally ill were the first to suffer from the Final Solution. In the mass killing of as many as a quarter million mentally ill people, the technology of the gas chamber and the disguise of gas chambers as showers were developed. Patients were taken to psychiatric centers and systematically put to death; local people spoke of the crematoriums, the black smoke, and the buses bringing them in as killing crates.
Lacking the checks and balances this country had until recently, it was relatively easy for Hitler to act. With war looming, the idea was to kill those deemed useless, and German psychiatry for the most part collaborated. This was symptomatic of the stigma and hopelessness attached to mental illness. Decent human beings and psychiatrists tended to recoil from becoming glorified boarding housekeepers keeping patients under lock and key or collaborating in the awfulness the Nazis perpetrated. Still thinking as they did by the end of the 19th century that mental illness was predominantly a biological problem, some began to suggest that biology could also provide the solution by intervening in biological systems to make people better.
America financially supported German psychiatric researchers with deep Nazi ties, like Ernst Rüdin, the key architect of Hitler's mass sterilization and extermination laws. The Nazis borrowed American narratives that these were lesser biological beings, and this financial support and these ties continued. The Rockefeller Foundation recognized that mental illness was an acute social problem, costly to the state and inflicting suffering.
Federal government involvement in medical and scientific research is a World War II and post-war development, partly due to the Cold War and Sputnik. Before the war, science and medicine were orphans that received little government money. Medical training reform was instead the product of investment by the enormously wealthy Rockefeller Foundation. Around 1930, the Foundation decided to concentrate its resources and chose psychiatry as its priority. It did so because psychiatric research was backward, it was a pressing public problem, and several trustees had direct experience with mental illness in their families—including wives institutionalized as schizophrenic, and one wife who murdered her children and killed herself, leaving her husband, a major actor in the Foundation, bereft and inclined to support research.
The Foundation supported various therapeutic experiments and work in genetics, including Ernst Rüdin in Germany, the leading researcher in genetics and mental disorder. Having absorbed lessons from California about sterilization, Rüdin became an enthusiastic proponent of it and a supporter of murdering mental patients. Ultimately, the beacon of hope for the future of humanity lies in the scientific method, as flawed as it is.
The Ice Pick Lobotomy
We can discuss therapeutic experiments on people who were shut up in a double sense: they were locked away, and their voices were not heeded because they were the product of madness. In the first five decades of the 20th century, people with various motivations, including the desire to improve the lot of the mentally ill, engaged in uncontrolled experiments with terrible results. The clearest and most extreme case in the public imagination is the lobotomy—the idea that you could solve psychotic breakdowns by excising part of the brain, initially by drilling holes in the skull and injecting alcohol or using what looked like a butter knife to break connections.
Walter Freeman, who his daughter said aspired to be the Henry Ford of lobotomy, sought to mechanize the process. He invented the ice pick lobotomy, where he rendered someone unconscious with two or three electric shocks, banged an ice pick through the orbit of the eye, and wiggled it about to sever connections. Freeman started his work in 1936, borrowing from Portuguese neurologist Egas Moniz, who won the Nobel Prize in medicine in 1949 for lobotomy. Because there were over half a million patients in America's mental hospitals, Freeman became convinced this operation was a cure-all. He traveled in a camper truck called the Lobotomobile, descending on state hospitals in the summer to teach the ice pick lobotomy. I came across a picture of a naked woman being dragged away by attendants to be lobotomized, resisting with all her might to no avail, and another of Freeman lobotomizing a patient in Washington State.
Freeman was ambidextrous; when he taught neurology, he could draw perfectly and simultaneously with both hands. When performing lobotomies, he switched hands when his right got tired, sometimes performing 20 or 30 in an afternoon. He boasted, "I could teach any damn fool to perform a lobotomy in twenty minutes even a psychiatrist," reflecting his contempt for psychiatrists as a neurologist.
Some lobotomists operated into the sixties or early seventies, but a younger generation rebelled after seeing the worst failures: the zombies on the back wards who were incontinent and had lost all mental power. They adopted antipsychotic drugs, which looked more like regular medicine and lacked those horrible overtones. In the popular mind, the most famous instance of these interventions is the film of Ken Kesey's novel One Flew Over the Cuckoo's Nest. Jack Nicholson gives the performance of a lifetime as a man given ECT—a dramatic rendition of what had happened in the past, though not what was occurring by the 1970s. When ECT doesn't smash him to bits, they lobotomize him, and the film ends with him being smothered to death because the Chief cannot bear to see him in that state.
Malaria "Cure" for Syphilis
We mentioned the asylum era from the mid-nineteenth into the twentieth century, discussing narratives and sterilization. Consider the insulin shock therapy from 1933 to the 1960s, where patients were put into deep hypoglycemic comas using large doses of insulin.
This era distinguished a group of patients suffering from general paralysis of the insane, or GPI. This involved the gradual loss of motor control—the ability to walk, swallow, and talk. These people thought they were Napoleon, Jesus Christ, the richest and sexiest man in the world, or Mary the mother of God. At the turn of the twentieth century, as many as twenty-five percent of people admitted to asylums suffered from GPI.
The Rockefeller Institute discovered that the organism causing syphilis resided in the brains of those with GPI; it was the tertiary stage of syphilis, similar to AIDS in the late nineteenth century. After the painful primary phase, syphilis goes underground and lurks like the chicken pox virus, surfacing years later. It is insidiously damaging, sometimes attacking the heart so people drop dead in their forties from what seems like a natural heart attack, or attacking the central nervous system, spinal column, and brain to cause paralysis and psychiatric symptomatology.
Developing a treatment for tertiary syphilis won a Nobel Prize, one of only two awarded for psychiatric innovations—the other being the lobotomy. The treatment involved giving people malaria to cure their syphilis. An Austrian doctor, Wagner Jauregg, believed fever could cure mental illness. After trying rat bite fever and the typhoid vaccine to no avail, he extracted malarial blood from a captured Italian soldier and injected it into patients with GPI, claiming it cured them. While he used vials of blood, mental hospitals often had actual colonies of malarial mosquitoes. Imagine being a mental patient in a straitjacket, unable to move in a room where mosquitoes buzz around and bite you until you develop malaria.
In 1937, Von Jauregg won a Nobel Prize. He thought malaria stimulated the immune system to attack the cause of insanity, or potentially burned parasites out of the brain by heating it to 105 or 106 degrees. Because people were unsophisticated about statistics and controlled trials had not yet come to pass, this treatment was used extensively for two decades. It died away with the discovery of penicillin, a real magic bullet.
This feeds into the narrative of desperate remedies between the mid-'teens and 1950. The discovery of the syphilitic origins of general paralysis of the insane occurred after medicine underwent a profound transformation. In the late 19th century, Louis Pasteur, a chemist, and Robert Koch in Germany uncovered the origins of various diseases, suggesting bacteria were why people sickened. This led to public health triumphs; while it didn't initially lead to antibiotics, phenomenally effective vaccines were developed for many diseases, including viral ones like rabies. This new germ theory transformed medicine, tying it to the laboratory and science.
Another transformation was the adaptation of Pasteur's theories by British surgeon Lister. Previously, people thought pus post-surgery was a good sign, but Lister argued nasty germs caused it and introduced antiseptic surgery, spraying carbolic acid on wounds to kill microbes. Eventually, we moved to aseptic surgery, using sterilized instruments in a sterilized environment.
At the time, 25% of mental hospital admits suffered from infectious diseases. The diphtheria vaccine, for example, warded off a leather-like membrane that grew over the throat and caused children to choke to death. Such breakthroughs dramatically improved medicine's image and financial prospects as training became more scientific. This didn't apply to psychiatry until syphilis provided a model for how an infectious agent could cause minds to go amok. Consequently, Emil Kraepelin, who invented the distinctions between schizophrenia and bipolar disorder, began to think there may be something infectious about the mental illnesses we treat.
One of the people he trains is Henry Cotton, a young American psychiatrist also trained by Adolf Meyer, the leading American psychiatrist of the first forty years of the twentieth century. After Cotton spends a year in Germany, Meyer secures him a position as head of the New Jersey State Mental Hospital at Trenton. Cotton is an ambitious reformer who wants to bring psychiatry back to medicine and chuck out the old stuff, removing chains and straightjackets.
However, nothing changes fundamentally; he still isn't curing patients. Then he discovers the idea of focal sepsis: that low-grade infections lurk in the body, releasing toxins into the bloodstream and lymph that may affect the brain. To remove the bacteria, they remove stomachs, spleens, and colons, claiming to cure eighty percent of patients. Rich patients from all over America come for this novel treatment.
Cotton gives a series of lectures at Princeton, some of which are given by Nobel Prize winners, and his work is published by Oxford University Press and Princeton University Press. The New York Times hails it as a great breakthrough, yet in reality, 45% of people who undergo the abdominal surgery die within a year. Cotton once wrote that stomachs are like cement mixers on a construction site and could be dispensed with. If you were released from Trenton with no teeth, people immediately knew you were an ex-patient because the word had spread.
This continues from 1916 until Cotton drops dead of a heart attack in 1933, but he is succeeded by three people he trained. They use colonic irrigation, and teeth and tonsils keep being pulled. I interviewed the dentist who joined the hospital in 1916 and must have pulled several hundred thousand teeth; he was convinced Cotton should have won the Nobel Prize.
These are powerful interventions conducted by people in white coats with stethoscopes and scalpels—powerful in their impact on the human body, not their effectiveness. The promise is: "What I am going to do to you will hurt and is very intimate, but it's going to make you better." This persists in contemporary psychiatry: trying to figure out how much improvement is the placebo effect versus the active effect. When you combine a gigantic, life-changing operation with lab coats and society telling you it will work, that is the most pure kind of placebo effect.
Insulin Coma Therapy
The placebo effect comes from both the patient who wants to believe they will get better and the person conducting the treatment.
Consider one of the real triumphs of 20th century medicine: the discovery of insulin in the 1920s. Like psychiatric drugs, it wasn't a cure, but a symptomatic treatment that transformed lives. Previously, what we now call type one or juvenile diabetes was a death sentence; insulin allows a relatively normal life and a greatly expanded lifespan. Those of us with Type Two diabetes, however, have bodies that resist insulin and must resort to other ways of coping.
A man named Sakel, working in a German clinic for drug addicts, used mild comas to help patients through withdrawal symptoms. When he moved to Austria, he tried this as a treatment for schizophrenia, putting people into comas that lasted hours or days, revived by glucose usually given intravenously. He claimed this Insulin Coma Treatment cured eighty percent of patients—a percentage that tends to recur in these treatments.
Invited to New York in 1936 after starting in 1933, Sakel demonstrated this at the Harlem Valley Mental Hospital and settled here. He built a lucrative private practice in New York, leaving his partner an estate of about two million dollars upon his death, a very substantial amount in the early sixties.
Insulin coma therapy was widely adopted, but its scale was limited because it required enormous nursing and medical attention. Patients hovered on the brink of life and death; they could die, enter a permanent coma, or suffer the loss of brain cells.
Insulin comas weren't subjected to a randomized controlled trial until the nineteen fifties, which they failed, and so the practice died out. Patients would thrash, moan, and convulse before falling into a coma, requiring a course of up to sixty comas. Despite a mortality rate of one to five percent and causing significant brain damage and obesity, it was hailed as a miracle cure for schizophrenia.
John Nash, one of the great minds of the 20th century, received insulin comas at Trenton State Hospital and was at risk of being lobotomized. Nash clearly became delusional, and these treatments were represented in the film A Beautiful Mind.
In Austria-Hungary during this period, another psychiatrist decided you couldn't be both schizophrenic and epileptic, reasoning that creating an artificial epileptic seizure might drive out the schizophrenia. He first tried injecting camphor, a natural substance that caused abscesses and was ineffective. He settled on Cardiazol, or Metrazol, depending on which side of the Atlantic you were on.
Injecting that usually caused a grand mal seizure where the body arcs back and legs contract dramatically, resulting in fractures of the vertebrae and the hip socket, where the thigh bone is driven into the socket at such a rate that it fractures. The psychiatrist conceded that between the injection and the seizure, the patient felt as though they were on the brink of death. You're brought in a straitjacket, a man in a white coat injects you with a big hypodermic, you feel as though you're going to die for two, three, or ten minutes, and then you seize.
Because people were not happy with this, electroconvulsive therapy, or electroshock, was developed. Two Italian psychiatrists, Cerletti and Bini, first experimented with electricity on dogs, using an electrode on the head and an electrode on the anus.
Electroconvulsive Therapy (ECT)
Electric current passing through the body stops the heart and kills dogs. Someone suggested visiting the Rome slaughterhouse to see pigs being slaughtered; as the pigs dangle by their hind legs, two electrodes cross their heads. Electroshock makes them convulse and unconscious before their throats are slit and pork arrives.
They tried that on dogs and found current passing through the brain doesn't kill them. They brought in a transient homeless person from the Rome train station and tried it. At first, they didn't use enough current. Descriptions show them discussing upping the current; the patient heard this and said, "No, another one, that's deadly." They did it anyway, and he convulsed in a grand mal seizure with spinal and hip fractures. He stopped breathing, then spontaneously started again, and when he came around, he was in contact with reality.
This miracle cure was easy to administer, cheap, and didn't involve injections, so it quickly spread across the Atlantic and Europe. ECT became a widely used intervention. It turned out not very useful for schizophrenia, despite the originally posited connection between seizures and schizophrenia, but it seemed to work for depression, particularly suicidal depression. It is one of the few evidence-based, scientifically backed methods that actually worked for serious clinical depression.
This was unmodified ECT, which ruled the roost into the 1950s and some places into the 1960s. It was associated with fractures and memory problems; while the severity is disputed, it's widely recognized as a price of treatment. In mental hospitals during the '40s and '50s, ECT was used more as a device to control behavior than as a therapeutic intervention.
We don't know why it "works," but more recent work starting in the 1990s—and I may get in trouble for saying this because some patients and psychiatrists swear by ECT—suggests memory problems and claims of brain damage. ECT changed when muscle relaxants were introduced so people didn't thrash, making fractures largely a thing of the past. Originally using curare and later more modern drugs to temporarily paralyze muscles, the procedure became more complicated, requiring anesthesiologists and breathing support. The thinking was that we'd sooner use those drugs, but they turn out to be only partially effective, and often pretty ineffective for suicidal cases or extreme melancholia.
ECT often has to be repeated at intervals as maintenance therapy, and memory problems can be quite severe. These are the patients who don't respond to drugs. The number of psychiatrists willing to give ECT is rather small, and in many states, it is hedged around with many legal restrictions.
In California, for example, ECT almost can't be given to involuntarily confined patients because you have to volunteer for it. There is a powerful group of psychiatrists, ex-patients, and people suspicious of modern medicine and science who are powerfully opposed to ECT. Although trials provide decent evidence that this works for some deeply distressed patients, it remains a controversial treatment.
On one side are those who think drugs are more powerful than they are, or who were successfully treated and say, "It worked for me, so stop criticizing it." On the other side are those for whom drug treatment failed, those left with terrible side effects, or a growing number of people so suspicious of medical science and drug companies that no amount of evidence will sway them. The Scientologists are an extreme example; they have a museum in Los Angeles titled Psychiatry: Industry of Death. Similarly, the resistance to vaccination in the contemporary US shows how trust has been destroyed for a substantial number of people, making it very difficult to convince them they are mistaken.
After four years of this, mistrust will have grown exponentially, and once trust is lost, it is very hard to recover. Secondly, the science itself is being destroyed. Clinical trials midway through were aborted, so that knowledge is lost. Scientists aren't being trained because funding has been cut, and established scientists no longer have the funding necessary to do their work. Since it takes six or seven years to train a scientist, four years without training means a decade is lost. What is lost is invisible because it is counterfactual. Medical research requires going down blind alleys and taking years to move from the laboratory to practical application. Eliminating a segment of that while diminishing trust in science is profoundly devastating; I likely won't live to see the consequences, but my children and grandchildren will.
Genetics was supposed to provide a clear picture of the origins of various mental diseases because they seem to run in families. The expectation was that once we decoded the human genome, we would quickly find a Mendelian gene or set of genes for schizophrenia. We now use genome-wide association studies, throwing everything in the kitchen soup into the picture without preconditions to see what relates to what. Using three hundred small variations in the genome, we can account for about ten percent of schizophrenia.
Psychiatric genetics has tended to undermine the distinctions we've made based on symptomatology. There is a great deal of overlap in the genetic abnormalities that heighten susceptibility to bipolar disorder, schizophrenia, or autism. As my friend Robin Murray, a British psychiatrist, says, schizophrenia seems to be the most serious, extreme end of a continuum of psychosis.
If leading psychiatrists speculate in ten years that there is no such thing as schizophrenia or bipolar disorder, I suspect that will badly affect people's trust in psychiatry, yet that is where the science may lead. I believe we need more humility, less arrogance, a greater willingness to confess the limits of what we can do, more awareness of the dangers of enthusiasm, and more skepticism toward claimed breakthroughs.
I worry about the tendency of science and medical journalism to hype things, which undermines trust when the hype proves unfounded. I see ketamine and psychedelics propounded as miracle cures for depression, though the evidence is enormously weak. I mentioned the 80% cure rates for Cotton's work, insulin coma therapy, and early asylums. Penicillin, I think, was a huge step.
Psilocybin in particular has been demonized for a long time, but Johns Hopkins is now conducting serious studies on cases where it is effective. Major journals like Science and Nature also tend to foreground things that make a big splash. Having many scientists working on these problems in different sites is very important as a check on enthusiasm and premature, unfounded claims.
One Flew Over the Cuckoo's Nest
Ken Kesey wrote this book about his own experience in a mental institution. Mental hospitals have a patchy, complicated history. Kesey worked in a hospital for veterans, which were largely created after the Second World War when psychiatric casualties among American troops were two to three times higher than in World War I. We know by osmosis that in the First World War, the military initially resisted but were ultimately forced to recognize shell shock. Consequently, post-war, the VA was heavily involved in paying to train psychiatrists and psychologists and had a considerable involvement with psychiatric disorders in its mental hospital system.
The book differs from the film. While the film is heavily indebted to the book, it changes various things. The novel is weirder, more political, and more about Chief Bromden's inner world and the combine, while the film is more naturalistic, character-driven, and turns McMurphy—the person who received ECT, played by Jack Nicholson—into the central hero. Louise Fletcher's performance as Nurse Ratched is equally powerful. In 2015, among the few contemporary films I used, One Flew Over the Cuckoo's Nest was the only one almost every 18, 19, and 20-year-old in my film-interested class had seen; if I showed them Alfred Hitchcock's Spellbound, there was no chance they'd seen it.
Oddly, a very different film appeared around the same time: I Never Promised You a Rose Garden. It is a much more sympathetic portrait of a Freudian psychiatrist, based on Frieda Fromm-Reichmann who worked at Chestnut Lodge in Maryland and treated schizophrenia with psychotherapy rather than drugs or physical intervention. This was a bestselling novel by a young girl who had been her patient with serious delusions and a complicated family background, and the film changed many things from the novel.
Madhouse: A Tragic Tale of Megalomania and Modern Medicine doesn't have a happy ending; it is not necessarily about mental health, but about the journey of the institution in relation to the health of a patient. Pat Barker's trilogy of novels about World War I and the treatment of shell shock was turned into a powerful film called Regeneration. Additionally, my friend, the novelist Patrick McGrath, wrote a book called Asylum.
I grew up on the grounds of Broadmoor, England's premier hospital for the criminally insane, and was babysat by some of the patients. One Flew Over the Cuckoo's Nest successfully recreates the poverty of the environment and the way staff often put patients down, ignored them, poked fun at them, or were physically abusive. An abusive element was almost inevitable in many mental hospitals. The people with the most contact with patients were the lowest paid, least respected ward attendants, with very few RNs. In large state mental hospitals, the doctor-to-patient ratio meant patients hardly ever saw a physician.
Beyond its polemical edge, it is remarkable that the chief psychiatrist in the film is the real head of Oregon State Mental Hospital. While there is exaggeration, ECT was used in the fifties and sixties overwhelmingly as a tool of discipline and control, though it was also used therapeutically.
Interestingly, while men were often more troubled by these conditions—except for syphilitic patients—women bore the brunt of these experiments. About 70% of Henry Cotton's treated patients were female. Records from various hospitals show that 60 to 70% of lobotomy patients were female. ECT also tends to be heavily female, complicated by the fact that it is used primarily for serious or treatment-resistant depression, a diagnosis more common among women. Conversely, personality disorders and ADHD are more common male diagnoses.
I recently learned a friend tried everything for depression twenty years ago; ECT was the last thing he tried, and it changed his life for the better. There are many abuses, such as the CIA-funded Ewen Cameron in Canada, who gave multiple ECTs a day, reducing people to a state where they couldn't walk, talk, feed themselves, or control their bowels. He claimed to build them back up, but many were left permanently damaged. I could recite many horror stories, but honestly, patients on the brink of suicide with long-running depressions describe ECT as lifesaving. Recent controlled trials provide enough evidence that we cannot simply call it a desperate remedy to be consigned to the dark ages, though we have no clue why it works.
It's a purely empirical treatment. If you have a curable form of cancer and the surgeon removes it, that's that. Even if our knowledge of human biology is primitive, we understand that cancer is cells dividing uncontrollably, damaging the body and eventually killing you, so the fact that we can surgically remove it is a big deal.
I have high blood pressure. Thanks to the pill I take every day, which has a few very minor side effects, my blood pressure is like a 20-year-old's. It turns what could have killed me via a stroke or a heart attack into a condition that's very well controlled.
I first conceived the idea of writing the book Desperate Remedies in 1981 while in London on a Guggenheim Fellowship at the Wellcome Institute. I hadn't done research in detail, but I was aware of things that had happened in the 1920s and '30s and thought that would be an interesting thing to study. Forty years later, in 2022, I finally did Desperate Remedies. I couldn't simultaneously write two things, but I'd work on one and, if I got tired, pick up the other for a bit. Having thought about those issues for forty years made a big difference to how I approached things and what I thought. As Thomas says, you either say the same thing over and over for forty years, or you learn new things, broaden what you know, and think differently because you realize you haven't grasped the full complexity of what you're looking at.
This is an arena of tremendous human suffering. In my book Madness in Civilization, I found that from the ancient Greeks and ancient China to now, every society I've studied has to cope with people who deviate so far from the norm of what we regard as culturally appropriate. They exist everywhere. The limits to our knowledge mean there's space to examine things in a very complicated way. These intellectual puzzles attracted very smart people, but there's a long way to go.
Freud and Psychoanalysis
We have glimmers of insight about how the mind works, but in the span of human history, we are in the very early days of understanding. One thread I find exciting and important to the history of psychiatry is psychotherapy. We have mentioned psychopharmacology, and it would be useful to discuss when the two clash and psychopharmacology wins over psychoanalysis for a time.
Let us start in the nineteenth century when talk therapy came to life in religious and psychoanalytic contexts. Late nineteenth-century psychiatry, confined to mental hospitals and incarcerated people, had become very biological. However, many people experienced sadness, confusion, loss of social relationships, and grief that caused great distress without requiring a mental hospital.
Nineteenth-century America spawned several new religions and variants of Christianity. The Seventh Day Adventists created a sanitarium for depressed congregants, later taken over by the Kellogg family. They ran a huge sanitarium—a farm to recover mental stability and health bound up with beliefs about diet and defecation—where Abraham Lincoln's widow, Tarzan, Henry Ford, and many prominent industrialists and politicians went. There were also the Mormons, or Church of Jesus Christ of Latter-day Saints, and Christian Science, invented by Mary Baker Eddy. Christian Science, which still has churches and reading rooms across America, developed the idea that disease did not exist. Faith healing tended to work better for psychiatric problems than for cancer, and Christian Science gained many followers, disproportionately women, treating those with milder mental disorders. Mark Twain, for example, was thoroughly dismissive of Mary Baker Eddy. In New England, the Emmanuel Movement, centered around the Church of the Emmanuel in Boston, attempted to bring medical and religious approaches together to help the mentally troubled.
Neurology emerged in America after the Civil War, which provided naturalistic experiments on what happens to the human brain and nervous system when bullets blow holes in the brain. A group of new specialists emerged claiming expertise in the brain and nervous system, including insanity, which was seen as a brain disease. This caused a conflict in the 1870s and '80s between neurologists and psychiatrists, though neurologists generally could not enter the asylums where the most seriously ill patients were.
Gradually, people with functional mental disorders began appearing in neurologists' waiting rooms alongside those with conditions like multiple sclerosis. This was the beginning of outpatient practice, which initially involved drugs and static electricity, as electricity was seen as dominating the body's workings. Most notoriously, Silas Weir Mitchell, a leading light of American neurology, developed the "rest cure": complete bedrest, high calories, and a complete lack of intellectual stimulation. Mainly aimed at women, this treatment was subjected upon Virginia Woolf, who claimed it practically drove her mad or made her worse. Weir Mitchell wrote two popular self-help bestsellers, including one called Wear and Tear, which argued that the pace of modern life, the telegraph, and the railway were all too much.
Your nervous system was overstressed. Either your batteries ran down or you overtaxed your system and went bankrupt. You got scrawny, nouveau, nervous, and twitchy, and you needed to build back your strength, including your nervous strength. The solution was Fat and Blood.
Over 120 years ago, people spoke of how anxiety-inducing society was. We talk in the exact same way today about social media and the internet. We look back on the nineteenth century in idyllic terms of a slower pace of life, but people then thought it was stressful in the same ways we do. There was a class of potential patients seeking help from neurologists, a few psychiatrists who had moved out of the asylum, and religious mental healing groups common at the beginning of the 20th century.
In 1909, a Viennese gentleman and two close colleagues traveled across the Atlantic on a German steamer to Worcester, Massachusetts, where Clark University was celebrating its 20th anniversary. Clark was set up to copy the German research university. The only comparable example then was Johns Hopkins in Baltimore, which developed the leading medical school by borrowing that German concept of mixing research, teaching, and patient care.
I tell the story of Sigmund Freud and Carl Jung coming to America to give a lecture in a cinematic way because America has been a defining place for psychiatric medicine. Many in-house histories portray this as the Freud conference, but Freud was almost an afterthought. The head of Clark was a psychologist interested in Freud, but there were about thirty speakers, including two Nobel Prize winners in physics, Franz Boas, the leading anthropologist of his generation, and several of Freud's fierce critics, one of whom, Stern, was on the same boat.
It is a mark of how advanced German medical science was in the late nineteenth and early twentieth century that Freud delivered his lectures in German. This wasn't a problem for the audience because they had all learned German to read medical literature. William James, who was thinking about the psychology of the human mind in interesting ways, attended a lecture and spoke with Freud. James was not impressed and also had a bad heart condition. A handful of people, some of the neurologists, were impressed.
Freud's lectures explicitly attacked religiously based psychotherapy, claiming psychotherapy is like a surgical operation on the mind that only thoroughly trained people should perform. While he didn't believe psychoanalysis must be practiced only by the medically qualified, the lecture focused on psychoanalysis. James Jackson Putnam, a well-connected Boston Brahmin and professor of neurology at Harvard, became a Freudian at that conference, despite the general view that talk therapy for a biological condition was a ridiculous idea.
Sigmund Freud is widely acknowledged as the father of psychoanalysis. He proposed that an unconscious mind is the source of many of our behaviors and that talking is the tool to delve deep into that mind. Freud was trained as a neurologist under the famous Charcot in Paris; he endeared himself to Charcot and helped his career by translating Charcot into German. He was accompanied to the Clark conference by two close disciples, including Carl Jung. Jung was supposed to inherit Freud's enterprise until the men had a serious falling out in 1913 and went their separate ways.
As one of his close friends and collaborators put it, Freud was a great Hater; if you fell out with him, it was bad news. You were excommunicated, as happened with Adler and especially Jung. Jung, a Swiss doctor at the major mental hospital in Zurich, was attracted to Freud and eventually persuaded him to go to America. Freud initially had a very low opinion of America, suggesting it be renamed Dollaría because it was only interested in the dollar. He felt American women were too pushy and powerful, and that the dreadful American food poisoned him. Despite this, America brought him some fairly rich patients, though the richest of all went to Jung.
In the 19th century, Freud's academic career in Vienna was failing. In the 1880s, he faced the prospect of either emigrating to America, which he regarded with horror, or reviving his career by studying under Jean-Martin Charcot, the era's most famous neurologist, who was lecturing on hysteria in Paris. Freud spent some months there and returned to the Viennese medical establishment imbued with Charcot's ideas. He started a consulting career with a senior friend, Josef Breuer, who had a large practice and referred patients to him.
Together, they became interested in hysteria. Breuer had treated Bertha von Pappenheim, known as Anna O., the Ur patient for psychoanalysis. Many patients used pseudonyms because their cases exposed their inner psychology. Anna O. had nursed her father through a fatal illness and developed depression and troubling physical symptoms. Breuer and Freud determined she was suffering from repressed memories and trauma. This became central to psychoanalysis: the idea that half-muttered memories lurking in the subconscious emerge as distorted, disruptive psychological symptoms. Freud later developed a more elaborate theory of this.
Breuer and Freud collaborated on Studies in Hysteria, a series of case vignettes of Freud's patients. Initially, Freud believed these patients had been sexually assaulted as children and hid the trauma from themselves, causing it to emerge in tortured forms. As his work developed, the notion of resistances emerged—the idea that you resist retrieving these memories. Only through long, painful work of bringing the unconscious into the conscious world can your personality be transformed. Crucially, early childhood experiences have a dramatic effect, a notion some biological psychiatrists would agree with today; traumatic experiences and loss deeply mark the human psyche with powerful long-term effects.
Freud added theories on psychosexual stages of childhood, focusing on the libido, the sex drive, and the repression and modification of sexuality as people grow. This eventually divided Freud and Jung, as Jung downplayed the sexual side of things after their break. Reflecting his training as a neurologist, Freud developed a complicated theory of mind and wrote an essay called Project for a Scientific Psychology to tie psychology back into neurology. He also wrote The Interpretation of Dreams, regarding dreams as an arena where suppressed memories reemerge in disguised form, marking an important step forward.
He becomes interested in slips of the tongue, so-called Freudian mistakes. Freud's structure of personality consists of three interacting parts: the id, the primitive unconscious driven by the pleasure principle seeking immediate gratification of basic drives like sex and aggression; the ego, the rational mediator operating under the reality principle to balance the id's demands with external reality; and the super ego, the internalized moral standards and ideals producing guilt or pride while striving for perfection. The conflicts and interactions between these entities create your mental universe and way of being in the world, often creating pathology that psychoanalysis can transform from grotesque unhappiness into ordinary unhappiness.
Initially, Jung treats one of the heirs to the International Harvester fortune. The McCormick family are as rich as the Rockefellers, Carnegies, and Vanderbilts. This patient, a US senator, commits suicide in 1925 after treatment from Jung when he fails to win reelection. Edith Rockefeller, who marries a McCormick, has many psychological issues and tries to persuade Jung to move to Chicago, promising him a mansion and her friends as patients, but Jung has no interest. She finally persuades him to accompany her on the liner to Zurich for treatment. Being agoraphobic and unable to leave her cocoon, she occupies a huge array of suites with her servants in Zurich. During a train journey, her chauffeur follows in a Rolls Royce in case she cannot bear it and must jump out at a station. She eventually becomes a Jungian analyst and writes Jung big checks. Jung then attracts Paul and Mary Mellon, and his works are published by Princeton University Press with a subvention from the Mellon Foundation.
Freud's ideas became popular among the American intellectual and artist class in the 1920s. World War I saw many soldiers break down from shell shock. The label intimates early theories that bursting shells and bombs physically shook the body and brain, accounting for symptoms like mutism, blindism, constant shaking, and nightmares. Consequently, Freud's ideas about the unconscious mind, trauma, and symptomatology acquired new significance. Psychiatrists stuck in asylums with psychotic patients generally rejected these ideas and talk therapy. The only partial exception was the federal mental hospital in Washington DC, where superintendent William Alanson White was somewhat sympathetic, though talk therapy was out of reach for thousands of severely disturbed patients.
Novelists, painters, playwrights, and the audience for elite culture embraced Freudian ideas. Freud noted that while some think his case histories lack the stamp of serious science because they read like short stories, he is driven to that style to unpack what is happening. Elements of psychological conflict and hidden motives naturally appealed to novelists and screenwriters. Modern artists, such as the Surrealists, were heavily influenced by the idea of extracting things from the subconscious. However, circa 1930, there were probably only three hundred psychoanalysts in North America.
WWII and Cognitive behavioral therapy (CBT)
Classical psychoanalysis involving five hours a week meant analysts couldn't treat many patients—a few thousand when there are hundreds of thousands in hospitals. That changes when Hitler starts killing Jews and psychoanalysts. Some escape to England and some to America. The most famous escapee is Freud himself and his daughter Anna; Princess Bonaparte, one of Freud's great supporters, bribes the Nazis to get him out. He travels by train to London, very sick with cancer of the jaw as he has been since the mid-'20s.
By 1940, before America entered the war, the number of analysts had more than doubled and psychoanalytic training became much more organized. Institutes outside university control managed the field. Universities were not yet the knowledge factories they became after the war. Psychoanalysis made a crucial mistake here; while controlling its training completely was great, it became a structural weakness when the center of gravity moved to the university and the field either resisted being incorporated or the university resisted incorporating it.
What really transforms things is World War II. Famously, sessions last fifty minutes so analysts have ten minutes to recover before the next patient arrives. You free associate on the couch, gradually being coaxed to see what you're hiding from yourself. In the early days, they tried hypnosis. Freud trained under Charcot, who hypnotized hysterical patients. We now know much of that was fakery; the patients were on display repeatedly, worked up routines, and deceived both Charcot and the audience. Freud returned from Paris believing hypnosis was the way forward, but after his break with Breuer—who had a general medical practice and lost interest in hysteria—Freud, a clumsy hypnotist by his own account, developed free association, letting people speak whatever came into their head without a censor.
After World War II, as psychoanalysis made great strides in America and the Rockefeller Foundation promoted psychiatry, funding program heads Alan Gregg and Robert Morison pressed analysts to provide proof that their work worked. Analysts responded that there is no easy measure because they are reconstructing entire personalities and ways of being. Meanwhile, another kind of psychotherapeutics emerged during and after the war as a rival to both psychiatry and psychoanalysis; initially not terribly successful, it became an increasingly important part of the story.
Before Pearl Harbor, American psychiatrists warned military brass and politicians that if they fought, they would face the same problems as in the First World War: psychologically vulnerable soldiers would break down. To avoid shell shock, they screened out 1 3/4 million people as unfit. However, those problems quickly reemerged because industrial warfare exposes people to seeing and doing things that all of us in normal life would recoil from.
From talking to people who've gone through this, many soldiers find the memories of their experiences intolerable. This became a huge problem for the American Army and all armies. While the Nazis just shot people, the Allies had to treat these troops to get them back into fighting lines or support positions. This issue created extraordinary morale problems and invited malingering, costing much of the fighting force; in combat conditions, as much as 25% of soldiers broke down.
Before the war, there were about 2,000 psychiatrists in the US; by the end, there were more than 2,000 in the US military alone. The second head of the US military psychiatric service was William Menninger from the Menninger Clinic in Kansas, where he and his brother ran a psychoanalytic treatment facility. He concluded the best treatment for these soldiers was psychotherapeutic. Because the origin of their condition was trauma, those recruited and retrained as psychiatrists absorbed a watered-down version of Freud's ideas. After the war, they formed a coherent group separate from the biologically oriented psychiatrists in state hospitals.
Another group emerged during the war because the military couldn't produce enough MD psychotherapists quickly enough, so psychologists were drafted to start outpatient treatment. By 1958, about 80% of psychiatrists worked in outpatient settings rather than hospitals. Clinically oriented psychologists developed a training program where students spent two years learning basic scientific psychology and research methods, followed by two or three years of clinical experience. This was clever because it allowed them to apply for federal grant money, which psychoanalysts, having no clue how to do so, almost never received.
These psychologists began treating symptoms. While psychoanalysts believed treating a symptom was like playing Whac-A-Mole—arguing that unless you deal with the underlying personality and the interaction between the id, ego, and superego, another symptom will pop up—clinical psychologists focused on the symptoms troubling people. They used what was initially cognitive behavioral therapy (CBT), and later interpersonal therapy and other variants, to develop techniques that worked relatively quickly on specific subsets of problems. Whether dealing with being socially snubbed, ignored, coworkers, or a disruptive child, these methods help you see your patterns and provide exercises for better coping. Additionally, CBT does not necessarily require five hours of therapy a week.
These therapies could be packaged, reproduced, and tested to create an evidentiary foundation. While a psychoanalyst would say treatment takes years and is hard to measure, these practitioners measured what happens when people are treated this way. Symptoms are what matter, not the underlying complex things psychoanalysts claimed to be treating. Consequently, it is shorter and reproducible, whereas every psychoanalytic patient is a new case with a new set of complicated issues.
Key figures here are Albert Bandura, Albert Ellis, and Aaron Beck. Bandura and other psychologists launched this movement, followed by Aaron Beck, who recently died at perhaps 100. There are videos of him talking at that age and he is still killing it, so wise. Beck is a remarkable figure because he was one of the first in the 1960s to show how unreliable psychiatric diagnosis was and how difficult it was to get psychiatrists to agree on what was wrong. Trained as a psychoanalyst who became disillusioned, his work had two important strands. He told his fellow psychiatrists that they were not very good at diagnosis, which was important for the movement towards DSM-III. Simultaneously, he broke with the idea that treating symptoms was a waste of time and joined psychologists to develop techniques to overcome self-destructive responses and improve the ability to interact. Interpersonal therapy is concerned with how the breakdown of relations with other people damages emotional stability, and how repairing those relationships helps it return.
Most of the world has socialized medicine, but America doesn't, so Americans were more willing to pay clinical psychologists to attack problems of everyday living—things that are often quite distressing.
If I look at the literature on CBT, for example, the evidence that it works for schizophrenia is pretty poor, and the evidence for milder conditions is more ambiguous than we like. The Cochrane Reviews, which systematically assess evidence for approaches to disease, say that at best the evidence for CBT is of low and medium confidence. However, there are patients for whom this helps; for milder forms of depression, I think CBT works better than drugs without the side effects. NICE, the British organization that determines which treatments the National Health Service will support based on evidence, has come to that same conclusion.
Cognitive behavioral therapy has surface-level intuitive elements, such as adjusting thought patterns, being aware of triggers that lead to a negative spiral, and basic habit changes that lead to a healthier life. But as you get more serious into the land of mental disorders, it becomes less conclusive. It makes sense that you have developed habitual, poor ways of responding to signals from the outside world, and habits are very hard to break. There is a lot of homework and exercises to reconfigure how you deal with the world. It is not for everybody, but there is a subset of people for whom this has positive effects.
Antipsychotics
Beyond lobotomies, there were talk therapy ideas like psychoanalysis and, from the clinical psychology side, cognitive behavioral therapy. Then psychopharmacology emerged, challenging that whole shebang of talk therapy. Hardly anybody had conceived that drugs could treat mental illness; while 19th and 20th-century mental hospitals used opiates, various hypnotics, marijuana, and alcohol to control or calm agitated patients, the idea that a drug could attack the underlying problem emerged by accident.
The drug industry emerged mostly in Germany, where the most advanced medicine was practiced in the late 19th century. From the chemical industry refining coal tar, we got aspirin. World War II greatly accelerated things, not least because we discovered a magic bullet called penicillin and subsequent antibiotics. Alexander Fleming famously observed penicillin in Petri dishes where bacteria had been killed, later winning a Nobel Prize and making capital from the discovery. However, Howard Florey and his team at Oxford developed its therapeutic potential. Florey flew some of it in his jacket across the Atlantic to America, where Americans solved the critical problem of mass production, as it had taken Florey's team weeks to develop enough to treat a single mouse.
Meanwhile, a French company named Rhône-Poulenc came across chlorpromazine, an antihistamine synthesized in Germany in the 1880s. Investigating new drug properties was a Wild West phenomenon, so Rhône-Poulenc sought a market for it. They considered it as an antiemetic for car sickness, or for eczema to stop scratching. Someone suggested it might work as an anesthetic potentiator, acting as a catalyst to reduce the amount of anesthetic needed because it made patients sleepy. Lieutenant Henri Laborit of the French Navy tried it as an anesthetic potentiator on patients awaiting surgery. In this era of lobotomies, he wrote to a relative in a Paris mental hospital, stating, "This works like a chemical lobotomy. These people don't care anymore about their surgery."
Lobotomy hadn't yet become the nasty word it would become. A colleague contacted Delay and Deniker at Saint-Anne's, the biggest mental hospital in Paris, suggesting the drug might work on psychiatric patients. When small doses failed, they gave larger doses, and sure enough, patients stopped acting out. They remained conscious but were less mobile and much calmer.
This is why Chlorpromazine—known as Largactil or Mighty Drug in Europe and Thorazine here—became known as a major tranquilizer. Hospitals saw it as a boon for controlling patients. It came to North America via Heinz Lehmann, a psychiatrist at the Protestant Hospital in Quebec. Though the Anglo-speaking elite oppressed French Canadians, Lehmann got the drug through the French connection. Rhône-Poulenc sold the rights to SmithKline French, who bought it thinking there wasn't much of a market. Within two years, two million people were taking it.
The companies sold it to politicians using moving pictures of agitated patients turning calm. This transformed SmithKline French from a small operator into a big company. Because chlorpromazine's molecule could be easily tweaked, copycat drugs emerged in America by 1954. In 1955, so-called minor tranquilizers entered the market, including Miltown, heavily promoted by television star Milton Berle, who called himself Uncle Miltown. These were muscle relaxant types, later joined or replaced in the '60s by Valium and Librium.
While Freudians wanted nothing to do with these drugs, hospital psychiatrists recognized the usefulness of Thorazine and its analogues. In the early '60s, they renamed major tranquilizers as antipsychotics, suggesting they attack the underlying psychosis. They change the forms of psychosis in important ways; they reduce agitation, delusions, and hallucinations—the positive symptoms of schizophrenia—for a significant number of patients. These positive symptoms are visible and activating. In contrast, the negative symptoms are things like apathy, loss of ability to interact with people, poverty of language, and lack of initiative.
Antipsychotics work on positive symptoms by dulling them down; you may still be hallucinating or delusional, but much less so, and you are somewhat pacified. They do not work on the negative side. Furthermore, these drugs work for some but not others, and a significant number of psychotic patients are non-drug responders, just as many people with depression are not responsive to antidepressants.
Initially, enthusiasm for these drugs led people to neglect their serious side effects, or argue that the side effects were an essential part of treatment. You may become incurably restless, constantly in motion and never still, which becomes unbearable to others and often to the person who can't control it. Other patients develop Parkinson's disease symptoms, an awful affliction affecting a significant number of people each year. We have L-DOPA to delay its impact, but that eventually loses efficacy and we have no cure.
Perhaps the nastiest is tardive dyskinesia. It is tardive because it is late developing and dyskinesia because it involves jerky, uncontrolled movements of the body, particularly the facial muscles; your tongue will protrude, you'll make strange noises, twitch, and stagger while walking. This problem was ignored for about 20 years until George Crane, a Maryland psychiatrist, published a paper in Science stating that the profession had been ignoring this terrible problem. By the '80s, the American Psychiatric Association was very worried.
In 1957, while people were developing copycat versions of Thorazine, clozapine was developed by a small company, bought by a bigger company, and introduced in Europe. First, it tended not to produce tardive dyskinesia, though many then thought that if you didn't get those symptoms, you weren't attacking the problem. Secondly, in a significant number of patients, it destroyed white blood cells and they died. As the tardive dyskinesia problem became more acute, there was an attempt to revive clozapine, which turns out to work better in treatment-resistant cases. It could be revived at the cost of weekly blood checks; if the white blood cell count started to drop, you had to stop. This whole class of drugs became known as second generation antipsychotics, which tend to have different side effect profiles, slightly different modes of action, and differing levels of efficacy.
Once the Drugs Revolution came along, studies were increasingly funded by drug companies who owned and controlled the data, releasing only what was helpful to them. You might have conducted 15 trials and 13 were failures, but two that worked was enough.
In 2005, the National Institutes of Mental Health funded the CATIE Study, published in the New England Journal of Medicine. First-generation drugs were out of patent and cheap, while second-generation drugs were patented and sometimes ten times as expensive. We compared one early first-generation antipsychotic against four more recent drugs to see if the new drugs were more efficacious and if patients were willing to tolerate them.
Between 67% and 82% of patients dropped out because the drugs didn't work or they couldn't stand the side effects. While there was somewhat less tardive dyskinesia, there was a whole new set of side effects. These pills often cause weight gain of 10, 20, 30, 40, or 50 pounds, leading to metabolic syndrome, diabetes, and heart trouble. Like an aspirin that may cause your stomach to bleed and put you in serious jeopardy, every drug has a main effect and side effects that may be minimal for most but worse for some.
We have no biological markers at the moment to tell us who will react how. Friends in psychiatric genetics research say that while we haven't found the genetic roots of mental illness, we may learn to distinguish which patients will respond well to drugs and which should not be given them. Beyond describable weight gain, some patients drop out because the richness of their mental life is completely gone, and they won't tolerate that.
Antidepressants
SSRIs like Prozac, Zoloft, and Paxil are the second generation of antidepressants. In the 1950s, while treating patients with advanced, lethal tuberculosis, doctors found that two new drugs made these depressed patients start acting happy and dancing about.
Around 1960, drug companies viewed depression as a small market, focusing only on the melancholic psychotic depressions that led people to mental hospitals. Now, depression is the common cold of psychiatry, the most commonly given diagnosis. This is partly due to a deeper understanding of the human mind and partly because drug companies convinced the world.
During the contemplation of DSM-5, there were big disputes over whether grief and bereavement—losing a parent or a child—would count as a form of depression. This is an example of "diagnostic creep," a term coined by an Australian named Nick Haslam. You start with a core of unambiguous deviations from the norm that any competent member of the culture recognizes, but then you begin to include a penumbra of people who are disturbed, though not sufficiently so for immediate recognition.
Allen Frances, the chief editor of DSM-IV, is convinced the huge increase in autism diagnoses is driven more by his loosening of the criteria than by more actual cases. There is a real difference between the most severe forms of autism, where people lose the capacity to speak and interact, and other serious but milder cases. Families have formed organizations like NAMI, but those aren't the mentally ill. Suffering from madness or mental health maladies is a deeply lonely experience; it is the most solitary of afflictions for the sufferer and the most social of maladies for those around them.
In the first generation, there were two kinds of antidepressants: MAOIs and tricyclics, which were called tricyclics because they had a third ring of a certain element in their molecule.
Those had a limited market and complications; it was easy to overdose and die. They could also kill you through dietary combinations—cheese and cured meats were health-threatening, maybe even fatal.
In the late '80s, drug companies found a new class of antidepressants without those side effects, the most famous being Prozac. These are SSRIs, or selective serotonin reuptake inhibitors. Serotonin is manufactured in our digestive system and performs various functions, but it is also a neurotransmitter in our brains. These drugs worked by slowing the reuptake of serotonin, which companies marketed as the solution to depression: you were depressed because you lacked enough serotonin, and these pills solved that problem.
Tipper Gore, Al Gore's ex-wife, was like many politicians' wives—depressed for reasons I partially or fully understand. Her psychiatrist gave her one of these, and she became a big public advocate for SSRIs, which remain the most prescribed antidepressants.
In controlled studies, these antidepressants beat placebos by a statistically significant margin, but not necessarily a clinically significant one; improving by one or two points on a 60-point scale may be enough for statistical significance. They come with difficult side effects. Many describe them as numbing drugs that flatten everything, removing the highs and lows of the human experience. In particular, many patients find a complete loss of libido; they cannot get an erection or climax, and sometimes their sex life doesn't return after stopping the drugs.
Getting off the drugs can be hell on wheels for some, who experience worse depression than before. Many patients find themselves trapped on those drugs for a long time, and we don't know the effects of that. That is why groups like NICE in England suggest using CBT as the first line, not drugs.
A recent Lancet study was revealing on this point for both antipsychotics and antidepressants. One group responds well with bearable or no side effects. Another significant group—40% or more of depressed patients—do not respond. In the middle is a group with some improvement but also side effects, making the cost-benefit analysis very difficult.
More importantly, the Drugs Revolution moved diagnosis and prescribing away from psychiatry alone; many antidepressants are now dispensed by primary care docs, not psychiatrists.
Future of Psychiatry
You probably need to try the drugs because the suffering is very intense, but you must be aware of the risks and have a clinician monitoring you carefully.
Psychiatric research needs to broaden. We have spent all our money on drugs, neuroscience, and genetics, but we should spend time on the psychosocial dimensions of mental illness to improve the lives of families and patients more immediately and allow psychiatrists to build careers in those fields. Currently, an academic psychiatrist's future depends on bringing in grant money, yet there are no grants available to study better ways to cope with homelessness or to ease the burden on families living with someone who is hallucinating.
We should also consider talk therapy, including cognitive behavioral therapy and psychoanalysis. Society left psychoanalysis behind, turning it into a niche product that only the very wealthy can afford and claim helps them. However, with the rapid improvement of artificial intelligence systems capable of communicating with humans and learning their deepest secrets—things you might be uncomfortable telling even a therapist—we enter the realm of Freud, Jung, and psychoanalysis. During the isolation of COVID, when people could not visit therapists directly, we saw a rise in distant learning, and some of this may indeed be mechanizable.
Public policy regarding serious mental illness is a mess, and I am pessimistic about fixing it because it would cost bunches of money. There would be incentive if we could cure people and transform them from "tax eaters" to taxpayers. Providing social supports and a sense of agency would be very helpful, as loneliness and isolation do bad things to people's mental health.
I hope someone produces a better drug because I would be astonished if the major forms of mental illness didn't have a biological component.
Major drug companies have been bad actors, abandoning research in this area. While their drugs have had some positive effects, it is depressing that those with the most money to develop better treatments are not doing so. This will be an important part of the story, but not the whole story.
The path forward is a mix of continued drug research and extreme caution in their use from a patient perspective. We need further investigation into talk therapy, whether CBT or psychoanalysis, and the psychosocial component of family and the people around you. From a cultural, social, and public policy perspective, we must investigate how to increase social connections for those who suffer, including breakthroughs for people who have a hard time making those connections or have lost the ability to make them.
Looking back at the rich history of human beings, we saw the darkness, but many people want to help those who suffer. Our profession has many well-meaning people who see this suffering face-to-face daily, and highly motivated people have done very good things to help. This requires a shift in the mentality of the whole profession toward a more caring, less technocratic direction with less reliance on simply giving people pills. While pills can help, they are clearly not the whole solution. We need a system aware of and catering to the suffering people experience, finding ways to ameliorate it in ways that people sense are actually helpful.